Lassa Viral Transmission and Immunoprotection: Defective Interfering Particles (DIPs) in Carrier Rodents and Lassa Virus-Infected People

拉沙病毒传播和免疫保护：带菌啮齿动物和拉沙病毒感染者中的缺陷干扰颗粒 (DIP)

• 批准号: 473816
• 负责人: Nadesalingam Angalee
• 金额: $ 10.93万
• 依托单位: Broad Institute of MIT and Harvard (Cambridge, MA)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-10-01 至 2025-10-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=473816&lang=en
• 关键词: Blood Samples Of People Of Lassa Endemic Southern Nigeria; Crispr-Cas13-Based Assay Development For Dips And Dvgs; Defective Interfering Particles (Dips)/Viral Genomes (Dvgs); Dips In Immunomodulation In People Of Lassa Endemic Area; Dips In Mastomys Nata; Blood Samples Of People Of Lassa Endemic Southern Nigeria; Crispr-Cas13-Based Assay Development For Dips And Dvgs; Defective Interfering Particles (Dips)/Viral Genomes (Dvgs); Dips In Immunomodulation In People Of Lassa Endemic Area; Dips In Mastomys Nata

The World Health Organization lists Lassa virus (LASV) as one of the of top 10 pathogens with high epidemic potential. LASV is currently endemic to West Africa, infecting up to 500,000 people, annually. It causes Lassa fever (LF) with symptoms ranging fro

世界卫生组织将LASSA病毒（LASV）列为具有高流行潜力的十大病原体之一。 LASV目前是西非特有的，每年感染多达50万人。它会引起拉萨热（LF），症状远。